Inspro Medical Acquired By OPKO

April 20, 2014 | American biopharmaceutical company OPKO Health has entered into a definitive agreement to acquire Inspiro Medical, an Israeli medical device company developing a new platform to deliver drugs to treat respiratory diseases. Inspiro’s Inspiromatic is a “smart” easy-to-use dry powder inhaler with several advantages over existing devices. Financial details of the transaction were not disclosed.